Are Systemic Inflammation Response Index and Systemic Immune-Inflammation Index an ideal biomarker for epileptic patients?

Author:

Sönmezler Abdurrahman1,Şanlı Zeynep Selcan1,Boz Pınar Bengi1,Keşkek Şakir Özgür2

Affiliation:

1. Department of Neurology, Adana Şehir Research and Training Hospital , Adana -Türkiye

2. Alaaddin Keykubat University School of Medicine Department of Internal Medicine- Division of General Internal Medicine Alanya/Antalya/Türkiye

Abstract

Abstract Background and Purpose inflammation is considered responsible for the pathogenesis of epilepsy. Inflammation plays a pivotal role in epilepsy.Various inflammatory markers are known related to epilepsy. No study has yet investigated the relationship between epilepsy and systemic inflammation response index (SIRI) and systemic immune-inflammation index (SII). This study aimed to evaluate the systemic inflammation response index (SIRI) and systemic immune-inflammation index (SII) in epilepsy. Methods This study included patients with epilepsy who presented to the neurology department within last five years. Results The epileptic group included 110 patients (63 males, 47 females) and the control group included 65 healthy individuals (33 males, 32 females). The mean age of the epilepsy (n = 110) and healthy control group (n = 65) was 33.0 ± 14.0 and 34.0 ± 10.2 years, respectively. SII and SIRI levels were 603.0 ± 469,6 and 1,42 ± 1,08 in the epileptic group and 567.6 ± 218.9 and 1,16 ± 0,58 in the control group. There were no significant differences between two groups (p > 0.05). Conclusion Our study results suggest that although is an associated with inflammation, SII and SIRI are still not an ideal biomarker for epileptic patients. This study is important because it investigated SII and SIRI in patients with epilepsy for the first time. Further prospective studies involving a larger sample size should be performed to have more valuable results for interpretation.

Publisher

Research Square Platform LLC

Reference26 articles.

1. Epilepsy in adults;-Thijs RD;Lancet,2019

2. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy;-Vezzani A;Nat Rev Neurol,2019

3. Epilepsy is a neurological and a systemic disorder;-Yuen AW;Epilepsy Behav,2018

4. -Vezzani A, Lang B, Aronica E (2016) Immunity and inflammation in epilepsy. Cold Spring Harb. Perspect. Med. 2016;6, a022699

5. Targeting crosstalk between Nuclear factor (erythroid-derived 2)- like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis;-Singh N;Int J Neurosci,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3